Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Prospective Randomized Controlled Trial of Efficacy and Safety of Granulocyte-colony Stimulating Factor Leukostim for Acute Ischemic Stroke.

NCT00901381 is registered in ClinicalTrials.gov with Clinical Institute of the Brain, Russia as lead sponsor.

NCT NCT00901381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00901381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Prospective Randomized Controlled Trial of Efficacy and Safety of Granulocyte-colony Stimulating Factor Leukostim for Acute Ischemic Stroke.
Lead sponsor
Clinical Institute of the Brain, Russia
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
February 28, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke